William Blair analyst Steven Lichtman initiates coverage on MiniMed Group (NASDAQ: MMED) with a Outperform rating.The analyst comments "MiniMed is ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage

BofA Securities Starts MiniMed Group (MMED) at BuyMarch 31, 2026 6:07 AM Evercore ISI Starts MiniMed Group (MMED) at OutperformMarch 31, 2026 6:01 AM BTIG Reiterates Buy Rating on MiniMed Group (MMED)March 31, 2026 5:47 AM Wells Fargo Starts MiniMed Group (MMED) at OverweightMarch 31, 2026 5:18 AM Mizuho Starts MiniMed Group (MMED) at OutperformMarch 31, 2026 5:07 AM Morgan Stanley Starts MiniMed Group (MMED) at OverweightMarch 31, 2026 5:03 AM Citi Starts MiniMed Group (MMED) at BuyMarch 31, 2026 5:01 AM Piper Sandler Starts MiniMed Group (MMED) at NeutralMarch 31, 2026 4:01 AM Form 4 MiniMed Group, Inc. For: Mar 25 Filed by: Dallara QueMarch 27, 2026 4:32 PM Form 8-K MiniMed Group, Inc. For: Mar 23March 27, 2026 4:10 PM